CN115916230A - 用于促进白细胞介素-10产生的组合物 - Google Patents

用于促进白细胞介素-10产生的组合物 Download PDF

Info

Publication number
CN115916230A
CN115916230A CN202180044666.5A CN202180044666A CN115916230A CN 115916230 A CN115916230 A CN 115916230A CN 202180044666 A CN202180044666 A CN 202180044666A CN 115916230 A CN115916230 A CN 115916230A
Authority
CN
China
Prior art keywords
lactic acid
fermented milk
acid bacteria
composition
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180044666.5A
Other languages
English (en)
Chinese (zh)
Inventor
利光孝之
河合良尚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Co Ltd
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of CN115916230A publication Critical patent/CN115916230A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/157—Lactis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202180044666.5A 2020-06-22 2021-06-21 用于促进白细胞介素-10产生的组合物 Pending CN115916230A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020107035 2020-06-22
JP2020-107035 2020-06-22
PCT/JP2021/023326 WO2021261423A1 (ja) 2020-06-22 2021-06-21 インターロイキン－１０の産生促進用組成物

Publications (1)

Publication Number Publication Date
CN115916230A true CN115916230A (zh) 2023-04-04

Family

ID=79281397

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180044666.5A Pending CN115916230A (zh) 2020-06-22 2021-06-21 用于促进白细胞介素-10产生的组合物

Country Status (5)

Country Link
US (1) US20230293605A1 (https=)
EP (1) EP4212165A4 (https=)
JP (1) JPWO2021261423A1 (https=)
CN (1) CN115916230A (https=)
WO (1) WO2021261423A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4104844A4 (en) * 2019-12-13 2024-02-14 Meiji Co., Ltd Composition for lowering heart rate
TW202241477A (zh) * 2020-12-16 2022-11-01 日商明治股份有限公司 腦組織之發炎改善用組成物
WO2025224073A1 (en) 2024-04-25 2025-10-30 Slimbiotics Gmbh Use of lactobacillus bacteria for reducing adipose and promoting muscle tissue

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
WO2013073424A1 (ja) * 2011-11-14 2013-05-23 株式会社明治 液状発酵乳及びその製造方法
CN103314099A (zh) * 2010-07-30 2013-09-18 株式会社明治 具有代谢综合症改善效果的乳酸菌
WO2017014290A1 (ja) * 2015-07-23 2017-01-26 株式会社明治 発酵乳およびその製造方法
WO2018038004A1 (ja) * 2016-08-22 2018-03-01 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
JP2018201401A (ja) * 2017-06-02 2018-12-27 株式会社明治 発酵乳の製造方法
CN111281895A (zh) * 2019-12-24 2020-06-16 顾青 用于治疗结肠炎的乳酸菌及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010896A (en) * 1991-06-24 2000-01-04 Becton, Dickinson And Company Lyophilized ionizing radiation sterilized microorganisms as an additive for nutrient media for growing bacteria
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
KR101014097B1 (ko) * 2008-06-18 2011-02-14 주식회사한국야쿠르트 대장의 건강 증진 효능을 갖는 락토바실러스 에스피. 에이취와이 7801 및 이를 유효성분으로 함유하는 제품
KR101501210B1 (ko) * 2012-07-31 2015-03-11 중앙대학교 산학협력단 항-염증 활성이 우수한 신규 균주
JP6478597B2 (ja) * 2014-12-02 2019-03-06 キユーピー株式会社 酢酸菌を有効成分とする乳酸菌増殖促進剤
JP6818405B2 (ja) * 2015-11-10 2021-01-20 キリンホールディングス株式会社 乳酸菌の免疫賦活作用を増強する方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
CN103314099A (zh) * 2010-07-30 2013-09-18 株式会社明治 具有代谢综合症改善效果的乳酸菌
WO2013073424A1 (ja) * 2011-11-14 2013-05-23 株式会社明治 液状発酵乳及びその製造方法
WO2017014290A1 (ja) * 2015-07-23 2017-01-26 株式会社明治 発酵乳およびその製造方法
WO2018038004A1 (ja) * 2016-08-22 2018-03-01 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
US20200016221A1 (en) * 2016-08-22 2020-01-16 Meiji Co., Ltd. Method for producing culture product of lactobacillus plantarum
JP2018201401A (ja) * 2017-06-02 2018-12-27 株式会社明治 発酵乳の製造方法
CN111281895A (zh) * 2019-12-24 2020-06-16 顾青 用于治疗结肠炎的乳酸菌及其应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
董伟 等: "植物乳杆菌胞外多糖对小鼠树突状细胞分泌的调控", 中国乳品工业, vol. 39, no. 6, 25 June 2011 (2011-06-25), pages 14 - 16 *

Also Published As

Publication number Publication date
US20230293605A1 (en) 2023-09-21
EP4212165A4 (en) 2024-07-31
WO2021261423A1 (ja) 2021-12-30
JPWO2021261423A1 (https=) 2021-12-30
EP4212165A1 (en) 2023-07-19

Similar Documents

Publication Publication Date Title
Sodini et al. Effect of milk base and starter culture on acidification, texture, and probiotic cell counts in fermented milk processing
Chandan Enhancing market value of milk by adding cultures
US11331353B2 (en) Sleep quality improver
JP7787936B2 (ja) 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
WO2011096808A1 (en) Use of sialyl oligosaccharides in weight management
CN115916230A (zh) 用于促进白细胞介素-10产生的组合物
JP7364390B2 (ja) 糖代謝改善用組成物
US9750776B2 (en) Agents for promoting secretion and/or suppressing decrease of adiponectin
WO2017047777A1 (ja) ストレス負荷解放後のセロトニン欠乏改善剤
Maity et al. Development of healthy whey drink with Lactobacillus rhamnosus, Bifidobacterium bifidum and Propionibacterium freudenreichii subsp. shermanii
US20240058398A1 (en) Composition for improving inflammation of brain tissue
Paongphan et al. Selected lactobacilli isolated from Thai foods for production of fermented dairy products with cholesterol lowering potential
JP2016113378A (ja) 濾胞性ヘルパーｔ細胞増加剤
WO2017047776A1 (ja) 血中トリプトファン濃度上昇抑制剤
JP7181954B2 (ja) 高いＡｈＲ活性化能を有する乳酸菌
CN116635516A (zh) 包含丙酸菌属菌或其处理物的组合物
JP7796537B2 (ja) 心拍数低下用組成物
JP7131913B2 (ja) 発酵乳及び乳酸菌スターターの製造方法
US10960033B2 (en) Compositions and methods for increasing or maintaining Faecalibacterium prausnitzii populations
WO2025047886A1 (ja) セロトニン産生促進用組成物
JP7333732B2 (ja) 筋肉量及び／又は筋力の維持、或いは筋肉量及び／又は筋力の低下抑制用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP5851242B2 (ja) チオレドキシン誘導活性を有する乳酸菌ならびにチオレドキシンを介する生体傷害の予防および／または改善用の飲食品および医薬品
WO2025047884A1 (ja) 細菌、組成物及び組成物の製造方法
JP2021042143A (ja) 脂質代謝異常及び／又は糖代謝異常の予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
Paongphan et al. NFS Journal

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination